63 related articles for article (PubMed ID: 23267767)
21. Hypoxia induces mucin expression and secretion in human bronchial epithelial cells.
Zhou X; Tu J; Li Q; Kolosov VP; Perelman JM
Transl Res; 2012 Dec; 160(6):419-27. PubMed ID: 23084780
[TBL] [Abstract][Full Text] [Related]
22. Hypoxic stress simultaneously stimulates vascular endothelial growth factor via hypoxia-inducible factor-1α and inhibits stromal cell-derived factor-1 in human endometrial stromal cells.
Tsuzuki T; Okada H; Cho H; Tsuji S; Nishigaki A; Yasuda K; Kanzaki H
Hum Reprod; 2012 Feb; 27(2):523-30. PubMed ID: 22128293
[TBL] [Abstract][Full Text] [Related]
23. CCAAT/enhancer-binding protein alpha antagonizes transcriptional activity of hypoxia-inducible factor 1 alpha with direct protein-protein interaction.
Yang L; Jiang Y; Wu SF; Zhou MY; Wu YL; Chen GQ
Carcinogenesis; 2008 Feb; 29(2):291-8. PubMed ID: 18024476
[TBL] [Abstract][Full Text] [Related]
24. Silibinin inhibits hypoxia-inducible factor-1alpha and mTOR/p70S6K/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: implications for anticancer therapy.
García-Maceira P; Mateo J
Oncogene; 2009 Jan; 28(3):313-24. PubMed ID: 18978810
[TBL] [Abstract][Full Text] [Related]
25. Casein kinase 2 inhibition decreases hypoxia-inducible factor-1 activity under hypoxia through elevated p53 protein level.
Hubert A; Paris S; Piret JP; Ninane N; Raes M; Michiels C
J Cell Sci; 2006 Aug; 119(Pt 16):3351-62. PubMed ID: 16882692
[TBL] [Abstract][Full Text] [Related]
26. (Aryloxyacetylamino)benzoic acid analogues: A new class of hypoxia-inducible factor-1 inhibitors.
Lee K; Lee JH; Boovanahalli SK; Jin Y; Lee M; Jin X; Kim JH; Hong YS; Lee JJ
J Med Chem; 2007 Apr; 50(7):1675-84. PubMed ID: 17328532
[TBL] [Abstract][Full Text] [Related]
27. HIF-1alpha and HIF-2alpha play a central role in stretch-induced but not shear-stress-induced angiogenesis in rat skeletal muscle.
Milkiewicz M; Doyle JL; Fudalewski T; Ispanovic E; Aghasi M; Haas TL
J Physiol; 2007 Sep; 583(Pt 2):753-66. PubMed ID: 17627993
[TBL] [Abstract][Full Text] [Related]
28. Hypoxia-inducible factor (HIF)-1 alpha directly enhances the transcriptional activity of stem cell factor (SCF) in response to hypoxia and epidermal growth factor (EGF).
Han ZB; Ren H; Zhao H; Chi Y; Chen K; Zhou B; Liu YJ; Zhang L; Xu B; Liu B; Yang R; Han ZC
Carcinogenesis; 2008 Oct; 29(10):1853-61. PubMed ID: 18339685
[TBL] [Abstract][Full Text] [Related]
29. Design, Synthesis and Structure-Activity Relationship Studies of Novel 4 (1-adamantyl) Phenyl Analogues as HIF-1α Inhibitors.
Xia Y; Duan Q; Zhao BH; Li DF; Hou RB
Med Chem; 2016; 12(4):338-46. PubMed ID: 26548744
[TBL] [Abstract][Full Text] [Related]
30. Synthesis, cytotoxicity for mimics of catalase: inhibitors of lactate dehydrogenase and hypoxia inducible factor.
Xue JJ; Chen QY; Kong MY; Zhu CY; Gen ZR; Wang ZL
Eur J Med Chem; 2014 Jun; 80():1-7. PubMed ID: 24763359
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis, and evaluation of indeno[2,1-c]pyrazolones for use as inhibitors against hypoxia-inducible factor (HIF)-1 transcriptional activity.
Fuse S; Suzuki K; Kuchimaru T; Kadonosono T; Ueda H; Sato S; Kizaka-Kondoh S; Nakamura H
Bioorg Med Chem; 2020 Jan; 28(1):115207. PubMed ID: 31740202
[TBL] [Abstract][Full Text] [Related]
32. Chemical biology approach for the development of hypoxia inducible factor (HIF) inhibitor LW6 as a potential anticancer agent.
Naik R; Han S; Lee K
Arch Pharm Res; 2015 Sep; 38(9):1563-74. PubMed ID: 26310207
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and structure-activity relationship study of chemical probes as hypoxia induced factor-1α/malate dehydrogenase 2 inhibitors.
Naik R; Won M; Ban HS; Bhattarai D; Xu X; Eo Y; Hong YS; Singh S; Choi Y; Ahn HC; Lee K
J Med Chem; 2014 Nov; 57(22):9522-38. PubMed ID: 25356789
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and evaluation of 3-(phenylethynyl)-1,1'-biphenyl-2-carboxylate derivatives as new HIF-1 inhibitors.
Wang S; Wang X; Shao Y; Shao K; Wang Y; Guo X; Dong H; Zhao W; Li Y; Li G
Bioorg Chem; 2021 Nov; 116():105298. PubMed ID: 34454298
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and biological evaluation of kresoxim-methyl analogues as novel inhibitors of hypoxia-inducible factor (HIF)-1 accumulation in cancer cells.
Lee S; Kwon OS; Lee CS; Won M; Ban HS; Ra CS
Bioorg Med Chem Lett; 2017 Jul; 27(13):3026-3029. PubMed ID: 28526370
[TBL] [Abstract][Full Text] [Related]
36. Boron-Based Drug Design.
Ban HS; Nakamura H
Chem Rec; 2015 Jun; 15(3):616-35. PubMed ID: 25800654
[TBL] [Abstract][Full Text] [Related]
37. Development of 1-aryl-3-furanyl/thienyl-imidazopyridine templates for inhibitors against hypoxia inducible factor (HIF)-1 transcriptional activity.
Fuse S; Ohuchi T; Asawa Y; Sato S; Nakamura H
Bioorg Med Chem Lett; 2016 Dec; 26(24):5887-5890. PubMed ID: 27847273
[TBL] [Abstract][Full Text] [Related]
38. Design and synthesis of nonsteroidal progesterone receptor antagonists based on C,C'-diphenylcarborane scaffold as a hydrophobic pharmacophore.
Fujii S; Yamada A; Nakano E; Takeuchi Y; Mori S; Masuno H; Kagechika H
Eur J Med Chem; 2014 Sep; 84():264-77. PubMed ID: 25036787
[TBL] [Abstract][Full Text] [Related]
39. Sulfonamides as a new scaffold for hypoxia inducible factor pathway inhibitors.
Tan C; de Noronha RG; Devi NS; Jabbar AA; Kaluz S; Liu Y; Mooring SR; Nicolaou KC; Wang B; Van Meir EG
Bioorg Med Chem Lett; 2011 Sep; 21(18):5528-32. PubMed ID: 21831638
[TBL] [Abstract][Full Text] [Related]
40. Effect of substituted bromoacetanilides on cytosolic aldehyde dehydrogenase.
Euston SE; Freeman GH; Kitson KE; Kitson TM
Adv Exp Med Biol; 1997; 414():233-41. PubMed ID: 9059626
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
